AXSM (Axsome) Sof foyda

AXSM (Axsome Therapeutics, Inc.) - kompaniyaning tovar belgisi

Axsome Therapeutics (AXSM) depressiyani davolashning zarur vositalarini ishlab chiqish orqali sezilarli narx belgilash imkoniyatiga ega. Kompaniya qadoqlashni avtomatlashtirish va klinik ma'lumotlarning raqamli validatsiyasini joriy qilmoqda. Kompaniyaning umumiy foydasi biznesning fundamental barqarorligini namoyish etadi va -0.19 parametrning joriy holatini belgilab, rahbariyatning R&D startapini daromadli farmatsevtika aktivga aylantirishdagi mahoratini tasdiqlaydi.

AXSM - Axsome Therapeutics Kompaniyaning sof foydasi 04.07.2022 - 29.10.2026 oraligʻida

Axsome Therapeutics, Inc. (AXSM) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Axsome Corp|AXSM - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Axsome Corp|AXSM - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Axsome Therapeutics|AXSM - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor kapitallashuvi axsome.com|AXSM - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Axsome Therapeutics|AXSM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Axsome|AXSM - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Axsome Corp|AXSM - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Axsome Therapeutics|Oraliq likvidlik koeffitsiyenti axsome.com
- foyda va bozor koeffitsiyentlari statistikasi:
AXSM - Sof foyda
Fundamental baholash:AXSM Axsome Corp
Axsome Therapeutics Inc brend mahsuloti

Kunlik sof foyda biznesning fundamental barqarorligini o'lchaydi, bunda haqiqiy moliyaviy natija va emissiyaning stress ssenariylaridagi xavfsizlik zaxirasi aks etadi. Axsome Therapeutics (AXSM) kompaniyasining operatsion natijalarini tahlil qilish orqali investor nevrologik dori vositalari ishlab chiqarishni autsorsing qilishning marjaga ta'sirini ko'rishi mumkin, chunki shaxsiy zavodlarning yo'qligi kapital xarajatlarini va ekologik xarajatlarni minimallashtiradi, bu esa bevosita yakuniy hisoblangan foyda darajalarida aks etadi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof foyda regencellbioscience.com|Sof daromad ACAD (ACADIA Pharmaceuticals Inc.)|Xenon Pharmaceuticals Inc. - Kompaniya foydasi|Kompaniyaning sof foydasi Viking Pharma VKTX|Sof moliyaviy natija Supernus Corp (SUPN)|CPRX - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi denalitherapeutics.com|Harmony Biosciences Holdings, Inc. (HRMY) - Kompaniyaning sof foydasi|Sof daromad Biohaven Ltd|AMLX (Amylyx) - Sof foyda|Kompaniyaning sof daromadi Trevi Corp TRVI|Sof daromad PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Yakuniy foyda|CeriBell - Sof daromad|Soliqlar to‘langandan keyingi foyda PRTA (Prothena Corp)|Alector Therapeutics - Sof foyda|Yakuniy foyda ANNX (Annexon Biosciences Inc.)|OMER: Sof foyda|Kompaniyaning sof daromadi neurogene.com (NGNE)|Kompaniyaning sof foydasi AC Immune SA|VYGR: Yakuniy foyda|Sof foyda NMRA|Sof foyda Scilex Holding Company, Inc. (SCLX)|Kompaniyaning sof foydasi Tevogen Bio Holdings TVGN|ACOG (Alpha Cognition Inc) - Soliqdan keyingi foyda|Cognition Therapeutics - Sof foyda|Kompaniyaning sof daromadi Inhibikase Therapeutics Inc|SAVA (Cassava) - Sof daromad|Assertio (ASRT) - Sof foyda|Sof daromad COYA|VTGN (VistaGen Therapeutics Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda OVID|Sof moliyaviy natija Acumen Pharmaceuticals Inc.|Sof foyda CRVO (CervoMed Inc)|ATHE - Sof daromad|CLNN - Kompaniyaning sof foydasi|Sof moliyaviy natija PepGen Inc. PEPG|JUNS: Sof foyda|Relmada Therapeutics Inc (RLMD) - Sof foyda|Sof daromad ANVS|Kompaniya foydasi GRCE (Grace Tx)|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Sof moliyaviy natija anewmeds.com|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|RVPH - Sof daromad|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Sof daromad NEUP|Sof foyda Minerva Neurosciences Inc|Kompaniyaning sof foydasi Athira (ATHA)|ADXN (Addex) - Yakuniy foyda|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|Protagenic - Sof foyda|KTTA - Sof foyda|CRGT (cortigent.com) - Sof daromad|Kompaniya foydasi ATXI|Kompaniyaning sof foydasi Brainstorm Cell|caratherapeutics.com (CARA) - Sof moliyaviy natija|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|ELYM - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|LBPH - Sof daromad|Marinus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi nkgenbiotech.com|NRBO (NeuroBo Pharmaceuticals, Inc.) - Sof daromad|Sage Therapeutics Inc. - Yakuniy foyda|Sof daromad SNPX|TRVN (Trevena Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda VIGL|WENA (Anew Medical Inc.) - Yakuniy foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)